UBS Group’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.6K Buy
120,242
+104,844
+681% +$35.4K ﹤0.01% 6642
2025
Q1
$10.1K Buy
15,398
+7,039
+84% +$4.6K ﹤0.01% 7338
2024
Q4
$8.02K Buy
8,359
+6,017
+257% +$5.78K ﹤0.01% 7194
2024
Q3
$2.74K Sell
2,342
-8,299
-78% -$9.71K ﹤0.01% 7167
2024
Q2
$14.3K Sell
10,641
-20,032
-65% -$26.8K ﹤0.01% 6369
2024
Q1
$56.7K Buy
30,673
+4,941
+19% +$9.14K ﹤0.01% 5293
2023
Q4
$61.5K Buy
25,732
+7,851
+44% +$18.8K ﹤0.01% 5237
2023
Q3
$60.3K Buy
17,881
+221
+1% +$745 ﹤0.01% 5052
2023
Q2
$100K Buy
17,660
+10,604
+150% +$60K ﹤0.01% 4968
2023
Q1
$40.3K Buy
7,056
+2,164
+44% +$12.4K ﹤0.01% 5519
2022
Q4
$32.1K Buy
4,892
+4,024
+464% +$26.4K ﹤0.01% 6002
2022
Q3
$13K Buy
+868
New +$13K ﹤0.01% 6960
2022
Q1
Sell
-2,710
Closed -$26K 9542
2021
Q4
$26K Buy
+2,710
New +$26K ﹤0.01% 6432